Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05785585Not ApplicableRecruiting

Effect of Methylcobalamin and Cyanocobalamin Consumption on Vitamin B12 Nutritional Status

Role: collaborator

NCT05454683Not ApplicableUnknown

Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Role: collaborator

NCT03000777Not ApplicableCompleted

Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)

Role: collaborator

NCT02148718Phase 4Completed

Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease

Role: collaborator

All 4 trials loaded